Your browser doesn't support javascript.
loading
A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01.
Graham, Peter H; Plant, Natalie; Graham, Jennifer L; Browne, Lois; Borg, Martin; Capp, Anne; Delaney, Geoff P; Harvey, Jennifer; Kenny, Lisbeth; Francis, Michael; Zissiadis, Yvonne.
Affiliation
  • Graham PH; Cancer Care Centre, St George Hospital, Kogarah, New South Wales, Australia. peter.graham@sesiahs.health.nsw.gov.au
Int J Radiat Oncol Biol Phys ; 86(1): 45-50, 2013 May 01.
Article in En | MEDLINE | ID: mdl-23414763
PURPOSE: A previous, unblinded study demonstrated that an alcohol-free barrier film containing an acrylate terpolymer (ATP) was effective in reducing skin reactions compared with a 10% glycerine cream (sorbolene). The different appearances of these products precluded a blinded comparison. To test the acrylate terpolymer principle in a double-blinded manner required the use of an alternative cream formulation, a moisturizing durable barrier cream (MDBC); the study was conducted by the Trans Tasman Radiation Oncology Group (TROG) as protocol 04.01. METHODS AND MATERIALS: A total of 333 patients were randomized; 1 patient was ineligible and 14 patients withdrew or had less than 7 weeks' observations, leaving 318 for analysis. The chest wall was divided into medial and lateral compartments, and patients were randomized to have MDBC applied daily to the medial or lateral compartment and sorbolene to the other compartment. Weekly observations, photographs, and symptom scores (pain and pruritus) were collected to week 12 or resolution of skin reactions if earlier. Skin dose was confirmed by centrally calibrated thermoluminescent dosimeters. RESULTS: Rates of medial and lateral compartment Common Toxicity Criteria (CTC), version 3, greater than or equal to grade 3 skin reactions were 23% and 41%, but rates by skin care product were identical at 32%. There was no significant difference between MDBC and sorbolene in the primary endpoint of peak skin reactions or secondary endpoints of area-under-the-curve skin reaction scores. CONCLUSIONS: The MDBC did not reduce the peak skin reaction compared to sorbolene. It is possible that this is related to the difference in the formulation of the cream compared with the film formulation. Skin dosimetry verification and double blinding are essential for radiation skin care comparative studies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Care / Radiation Injuries / Radiation-Protective Agents / Skin / Acrylates / Skin Cream / Glycerol Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2013 Document type: Article Affiliation country: Australia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Care / Radiation Injuries / Radiation-Protective Agents / Skin / Acrylates / Skin Cream / Glycerol Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2013 Document type: Article Affiliation country: Australia Country of publication: United States